Insulin receptor-sensitising polyaminosterols as a novel therapeutic approach for the treatment of type 2 diabetes
R. Govers
(1, 2)
,
T. Gonzalez
(2)
,
N. Zaarour
(2)
,
M. Berenguer
(2)
,
Y. Le Marchand-Brustel
(3)
,
J. -F. Tanti
(3)
,
F. Bost
(3)
,
V. Corcelle
(3)
,
J. Zhang
(4)
,
T. Xu
(4)
,
J. M. Brunel
(5)